Tobias J Lange
Overview
Explore the profile of Tobias J Lange including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yogeswaran A, Grimminger J, Tello K, Becker L, Seeger W, Grimminger F, et al.
Pulm Circ
. 2024 Aug;
14(3):e12397.
PMID: 39105131
The PEGASUS study is the first multicentric and prospective assessment of the safety of air travel flying in pulmonary hypertension (PH) (NCT03051763). Data of air travel from 60 patients with...
2.
Lange T, Escribano-Subias P, Muller A, Fernandes C, Fontana M, Remenova T, et al.
Adv Ther
. 2024 Jul;
41(9):3645-3663.
PMID: 39083197
Introduction: Risk assessment can aid management of pulmonary arterial hypertension (PAH) and clinical decision-making. This analysis describes characteristics, treatment patterns and outcomes of patients with PAH, categorised by risk status...
3.
Gaine S, Escribano-Subias P, Muller A, Fernandes C, Fontana M, Remenova T, et al.
Pulm Circ
. 2024 Jul;
14(3):e12403.
PMID: 39076250
Selexipag is indicated for the treatment of pulmonary arterial hypertension (PAH), including PAH associated with connective tissue disease (CTD), and further insights into the management of selexipag-treated PAH-CTD patients in...
4.
Goetz A, Poschenrieder F, Steer F, Zeman F, Lange T, Thurn S, et al.
Cardiovasc Intervent Radiol
. 2024 Apr;
47(5):621-631.
PMID: 38639781
Purpose: CT-guided percutaneous core biopsy of the lung is usually performed under local anesthesia, but can also be conducted under additional systemic opioid medication. The purpose of this retrospective study...
5.
Gerhardt F, Fiessler E, Olsson K, Kayser M, Kovacs G, Gall H, et al.
Circulation
. 2024 Apr;
149(20):1549-1564.
PMID: 38606558
Background: Among patients with pulmonary arterial hypertension (PAH), acute vasoreactivity testing during right heart catheterization may identify acute vasoresponders, for whom treatment with high-dose calcium channel blockers (CCBs) is recommended....
6.
Muller A, Escribano-Subias P, Fernandes C, Fontana M, Lange T, Soderberg S, et al.
Adv Ther
. 2024 Jan;
41(3):1103-1119.
PMID: 38216826
Introduction: Further insights into real-world management and outcomes of patients with pulmonary arterial hypertension (PAH) are needed. This interim analysis of the ongoing, multicentre, prospective EXPOSURE (EUPAS19085) observational study describes...
7.
Grunig E, Halank M, Neurohr C, Behr J, Milger-Kneidinger K, Ronczka J, et al.
Pneumologie
. 2023 Nov;
77(11):901-906.
PMID: 37963479
Within the last decade, the age at diagnosis of patients with pulmonary arterial hypertension has increased, which led to a change of the clinical phenoype being associated with more comorbidities....
8.
Klose H, Harbaum L, Richter M, Lichtblau M, Marra A, Kabitz H, et al.
Pneumologie
. 2023 Nov;
77(11):890-900.
PMID: 37963478
The 2022 guidelines on pulmonary hypertension from the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) provide therapeutic strategies that account for the variability in the clinical...
9.
Distler O, Ofner C, Huscher D, Jordan S, Ulrich S, Stahler G, et al.
Rheumatology (Oxford)
. 2023 Jul;
63(4):1139-1146.
PMID: 37462520
Objectives: Pulmonary arterial hypertension (PAH) occurs in various connective tissue diseases (CTDs). We sought to assess contemporary treatment patterns and survival of patients with various forms of CTD-PAH. Methods: We...
10.
Bordag N, Nagy B, Zugner E, Ludwig H, Foris V, Nagaraj C, et al.
medRxiv
. 2023 Jun;
PMID: 37292870
Background: Pulmonary hypertension (PH) poses a significant health threat with high morbidity and mortality, necessitating improved diagnostic tools for enhanced management. Current biomarkers for PH lack functionality and comprehensive diagnostic...